|
Buyback Record Date | |
Buyback Open Date | Dec 14, 2022 |
Buyback Closing Date | Jun 13, 2023 |
Issue Size (Amount) | ₹11.60 Crores |
Buyback Price | ₹702 per Share |
Jan 12, 2023 1:46:00 AM
Submission of details of Extinguishment of equity Shares pursuant to Buyback of shares by the Company for the period from 23rd December, 2022 to 5th January, 2023 ...
Publish by : money.rediffDec 13, 2022 4:20:00 PM
JENBURKT PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares. Download < Back: 05:05 PM : Please find enclosed the details of the daily ...
Publish by : money.rediffJan 30, 2023 3:29:00 AM
Please find enclosed the details of the daily reporting of shares brought back by the Company on 20.01.2023 ...
Publish by : Business StandardDec 23, 2022 3:30:00 AM
Stock score of Jenburkt Pharmaceuticals Ltd moved up by 1 in a month on a 10 point scale (Source: Refinitiv). Get detailed report on Jenburkt Pharmaceuticals Ltd by subscribing to ETPrime.
Publish by : IndiatimesOct 18, 2022 3:44:00 AM
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Publish by : Yahoo FinanceJan 8, 2023 9:59:00 AM
The IPO page of Jenburkt Pharmaceuticals Ltd. captures the details on its Issue Open Date, Issue Close Date, Listing Date, Face Value, Price band, Issue Size, Issue Type, and Listing Date's Open Price ...
Publish by : IndiatimesDec 24, 2022 10:06:00 AM
Jenburkt Pharmaceuticals Ltd is seeking SALES professionals with 3 to 6 years of experience in selling of pharmaceutical products. Position will be based at Bangalore, Pune & Mumbai. Interested ...
Publish by : LinkedInJun 15, 2016 9:22:00 PM
Aceclofenac is a nonsteroidal anti-inflammatory drug (NSAID), prescribed for fever and to relieve pain and swelling in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It blocks ...
Publish by : MedindiaJan 2, 2023 1:09:00 PM
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Publish by : InvestingFeb 15, 2022 2:55:00 AM
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex ...
Publish by : InvestingRead Jenburkt Pharmaceuticals Buyback current news. Find Jenburkt Pharmaceuticals Buyback subscription news, Buyback analysis, broker reviews, allotment news, and listing date. Get the Jenburkt Pharmaceuticals Ltd Buyback grey market premium and Jenburkt Pharmaceuticals Buyback expected listing price.
Add a public comment...
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|